Inactive Instrument
Stemcell Holdings, Inc. Stock Other OTC
Stocks
STMM
US85858N2027
Pharmaceuticals
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Masato Ozawa
CEO | Chief Executive Officer | 67 | 24/05/2021 |
Gabriel Garcia
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kato Hirotaro
LAW | General Counsel | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 1.64M | |
| +0.63% | -3.06% | +16.50% | -10.12% | 66.74B | |
| +1.23% | +2.80% | +38.09% | +200.66% | 53.32B | |
| +10.08% | +51.80% | +51.80% | +51.80% | 48.12B | |
| -1.32% | -7.38% | -57.37% | -56.96% | 38.25B | |
| +0.78% | -1.84% | +53.73% | -25.20% | 29.85B | |
| +0.84% | +0.36% | +67.62% | +84.46% | 23.51B | |
| -5.17% | -12.54% | +58.33% | -55.63% | 21.45B | |
| -1.21% | +1.12% | +0.90% | +164.17% | 19.97B | |
| +1.31% | +3.24% | +81.47% | +157.97% | 16.47B | |
| Average | +0.72% | -0.53% | +34.56% | +56.79% | 35.3B | |
| Weighted average by Cap. | +1.48% | +0.11% | +29.07% | +51.17% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 3.34M 2.93M 2.73M 2.5M 4.7M 322M 4.77M 32.38M 12.65M 158M 12.53M 12.26M 547M | 6.18M 5.43M 5.05M 4.63M 8.7M 595M 8.84M 59.94M 23.42M 293M 23.2M 22.7M 1.01B |
| Net income | 1.4M 1.23M 1.15M 1.05M 1.98M 135M 2.01M 13.6M 5.31M 66.4M 5.26M 5.15M 230M | 2.41M 2.12M 1.97M 1.81M 3.39M 232M 3.45M 23.37M 9.13M 114M 9.05M 8.85M 394M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
